U.S. Physical Therapy (USPH) Reiterated at Market Outperform by Citizens

Citizens analyst Constantine Davides reiterated a Market Outperform rating and $98.00 price target on U.S. Physical Therapy (NYSE: USPH).

The analyst commented, "We reaffirm our Market Outperform rating on U.S. Physical Therapy (USPH) ahead of our annual Healthcare Services Forum on June 25 in Boston. We believe investors are focused on the hospital strategy, M&A opportunities in PT and IIP, the potential for consolidated operating margin expansion, and the sustainability of rate improvements in both commercial and Medicare."

For an analyst ratings summary and ratings history on U.S. Physical Therapy click here. For more ratings news on U.S. Physical Therapy click here.

Shares of U.S. Physical Therapy closed at $63.50 yesterday.

You May Also Be Interested In

• T-Mobile (TMUS) PT Lowered to $235 at UBS Following Q2 Results
• RTX Corp. (RTX) PT Raised to $215 at UBS, Neutral Rating Maintained Given Premium Valuation
• Intel (INTC) PT Raised to $100 at DA Davidson Following Strong Q2 Results